Search
for
Sort by
Research 541–570 of 1000+
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Oral Baricitinib Restores Hair Loss in Alopecia Areata
- Annual Convention in the Time of COVID
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- One of the best treatments for alopecia areata remains unpublished
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- Treatment of severe alopecia areata with oral tofacitinib: A case series
- Alopecia Areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Answer
- Severe scarring alopecia associated with combinational use of ficlatuzumab and gefitinib: a clinical and immunohistochemistry study
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Alopecia Areata: Current and Emerging Therapies
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- S3‐Leitlinie Diagnostik und Therapie der Alopecia areata – Teil 2: Therapie, psychosoziale und kosmetische Unterstützung
- When hair dig into the brain, JAKi , may help!
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM